NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. FABRAZYME® [fab-ra-ZIME] Agalsidase beta-rch [ag-al-SI-daze bee-ta R.C.H]
Continue reading »
Celaxib (New Formulation)
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CELAXIB contains the active ingredient celecoxib CONSUMER
Continue reading »
APO-Pravastatin
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-PRAVASTATIN TABLETS Contains the active ingredient pravastatin
Continue reading »
DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19
RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board
Continue reading »
Mabthera (RA/GPA/MPA)
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MABTHERA IV RA, GPA & MPA 190809
Continue reading »
Opdivo
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OPDIVO CMI _V17.0 (op-DEE-voh) Nivolumab (nee-vol-u-mab) Consumer
Continue reading »
Torisel
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TORISEL® Temsirolimus Concentrate for Injection Consumer Medicine
Continue reading »
Diovan
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. DIOVAN® Valsartan Consumer Medicine Information What is
Continue reading »
Omacor
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OMACOR® Omega-3-acid ethyl esters 90 (includes EPA
Continue reading »
Exelon
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. EXELON® Rivastigmine hydrogen tartrate Consumer Medicine Information
Continue reading »